- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Advances in Virology
Volume 2011 (2011), Article ID 797820, 4 pages
Lack of Detection of Xenotropic Murine Leukemia Virus-Related Virus in HIV-1 Lymphoma Patients
1Viral Mutation Section, HIV Drug Resistance Program, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD 21702, USA
2Protein Expression Laboratory, SAIC-Frederick Inc., NCI-Frederick, Frederick, MD 21702, USA
3HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Received 17 June 2011; Accepted 11 July 2011
Academic Editor: Yoshinao Kubo
Copyright © 2011 Krista A. Delviks-Frankenberry et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. Urisman, R. J. Molinaro, N. Fischer et al., “Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant,” PLoS Pathogens, vol. 2, no. 3 article e25, pp. 211–225, 2006.
- R. Schlaberg, D. J. Choe, K. R. Brown, H. M. Thaker, and I. R. Singh, “XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 38, pp. 16351–16356, 2009.
- G. Simmons, S. A. Glynn, J. A. Holmberg et al., “The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans,” Transfusion, vol. 51, no. 3, pp. 643–653, 2011.
- V. C. Lombardi, F. W. Ruscetti, J. D. Gupta et al., “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome,” Science, vol. 326, no. 5952, pp. 585–589, 2009.
- C. Chaipan, K. A. Dilley, T. Paprotka et al., “Severe restriction of xenotropic murine leukemia virus-relate virus replication and spread in cultured human peripheral blood mononuclear cells,” Journal of Virology, vol. 85, no. 10, pp. 4888–4897, 2011.
- T. Paprotka, N. J. Venkatachari, C. Chaipan et al., “Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs,” Journal of Virology, vol. 84, no. 11, pp. 5719–5729, 2010.
- H. C. T. Groom, M. W. Yap, R. P. Galão, S. J. D. Neil, and K. N. Bishop, “Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 11, pp. 5166–5171, 2010.
- N. Maeda, H. Fan, and Y. Yoshikai, “Oncogenesis by retroviruses: old and new paradigms,” Reviews in Medical Virology, vol. 18, no. 6, pp. 387–405, 2008.
- R. Yarchoan, G. Tosato, and R. F. Little, “Therapy insight: AIDS-related malignancies–the influence of antiviral therapy on pathogenesis and management,” Nature Clinical Practice Oncology, vol. 2, no. 8, pp. 406–415, 2005.
- S. Hong, E. A. Klein, J. Das Gupta et al., “Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (Xenotropic Murine leukemia virus-Related Virus), a human retrovirus associated with prostate cancer,” Journal of Virology, vol. 83, no. 14, pp. 6995–7003, 2009.
- K. J. Kunstman, T. Bhattacharya, J. Flaherty, J. P. Phair, and S. M. Wolinsky, “Absence of xenotropic murine leukemia virus-related virus in blood cells of men at risk for and infected with HIV,” AIDS, vol. 24, no. 11, pp. 1784–1785, 2010.
- S. Tang, J. Zhao, R. Viswanath et al., “Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus Type 1-infected blood donors or individuals in Africa,” Transfusion, vol. 51, no. 3, pp. 463–468, 2011.
- M. Cornelissen, F. Zorgdrager, P. Blom et al., “Lack of detection of XMRV in seminal plasma from HIV-1 infected men in The Netherlands,” PLoS ONE, vol. 5, no. 8, Article ID e12040, 2010.
- E. Barnes, P. Flanagan, A. Brown et al., “Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections,” Journal of Infectious Diseases, vol. 202, no. 10, pp. 1482–1485, 2010.
- T. J. Henrich, J. Z. Li, D. Felsenstein et al., “Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions,” Journal of Infectious Diseases, vol. 202, no. 10, pp. 1478–1481, 2010.
- E. R. Gray, J. A. Garson, J. Breuer et al., “No evidence of XMRV or related retroviruses in a london HIV-1-positive patient cohort,” PLoS ONE, vol. 6, no. 3, 2011.
- A. L. Aloia, K. S. Sfanos, W. B. Isaacs et al., “XMRV: a new virus in prostate cancer?” Cancer Research, vol. 70, no. 24, pp. 10028–10033, 2010.
- O. Hohn, H. Krause, P. Barbarotto et al., “Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients,” Retrovirology, vol. 6, article no. 1742, p. 92, 2009.
- S. Hue, E. R. Gray, A. Gall et al., “Disease-associated XMRV sequences are consistent with laboratory contamination,” Retrovirology, vol. 7, no. 1 article 111, 2010.
- B. Oakes, A. K. Tai, O. Cingoz et al., “Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences,” Retrovirology, vol. 7, article 109, 2010.
- M. J. Robinson, O. W. Erlwein, S. Kaye et al., “Mouse DNA contamination in human tissue tested for XMRV,” Retrovirology, vol. 7, article 108, 2010.
- E. Sato, R. A. Furuta, and T. Miyazawa, “An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR Kit is amplified using standard primers for XMRV,” Retrovirology, vol. 7, article 110, 2010.
- J. A. Garson, P. Kellam, and G. J. Towers, “Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection,” Retrovirology, vol. 8, article 13, 2011.
- T. Paprotka, K. A. Delviks-Frankenberry, O. Cingöz et al., “Recombinant Origin of the Retrovirus XMRV,” Science, vol. 333, no. 6038, pp. 97–101, 2011.